Results 21 to 30 of about 101,665,842 (264)

Prevalence of lean type 2 diabetes mellitus in recently diagnosed type 2 diabetes mellitus patients

open access: yesIndian Journal of Endocrinology and Metabolism, 2013
Introduction: Obesity has always been thought to be a risk factor for diabetes; however, some studies in India have reported that even lean people are prone to diabetes.
Prateek Chaudhary   +2 more
doaj   +1 more source

Relationship Between Family Support and Diet Compliance in Diabetes Mellitus Patients Type 2 in Internal Disease Poly RSU Karsa Husada Batu

open access: yesJurnal Keperawatan dan Fisioterapi, 2022
Diabetes mellitus is a chronic disease which is one of the health problems in Indonesia with a prevalence of 24.49 million people. One of the management of diabetes mellitus is diet therapy.
Chindy Surya Kencana   +2 more
doaj   +1 more source

The impact of type 2 diabetes and Microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial Disease (SMART) study [PDF]

open access: yes, 2008
Aims Type 2 diabetes mellitus and microalbuminuria are important risk factors for cardiovascular disease (CVD). Whether these two complications are important and independent risk factors for future CVD events in a high-risk population with clinically ...
Graaf, Y., van der   +3 more
core   +1 more source

Common variants of the TCF7L2 gene are associated with increased risk of type 2 diabetes mellitus in a UK-resident South Asian population [PDF]

open access: yes, 2008
Background Recent studies have implicated variants of the transcription factor 7-like 2 (TCF7L2) gene in genetic susceptibility to type 2 diabetes mellitus in several different populations. The aim of this study was to determine whether variants of this
Barnett Anthony H   +28 more
core   +2 more sources

HYPERTENSION AND DIABETES MELLITUS TYPE 2

open access: yesРациональная фармакотерапия в кардиологии, 2018
Aim. To study the effect of long-term combined antihypertensive therapy with lisinopril plus amlodipine on the parameters of central aortic pressure (CAD) and visceral obesity in patients with arterial hypertension (HT) combined with type 2 diabetes ...
M. E. Statsenko, M. V. Derevyanchenko
doaj   +1 more source

Pre-existing diabetes mellitus and adverse pregnancy outcomes [PDF]

open access: yes, 2012
Background Pregnancies complicated by pre-existing diabetes mellitus (PDM) are associated with a high rate of adverse outcomes, including an increased miscarriage rate, preterm delivery, preeclampsia, perinatal mortality and congenital malformations ...
Fayed, Amel   +9 more
core   +1 more source

Genes and type 2 diabetes: polymorphisms of the EIF2AK3 gene and its relationship to type 2 diabetes mellitus [PDF]

open access: yes, 2010
MDAims/ Hypothesis: Wolcott- Rallison syndrome (WRS) is a rare autosomal recessively inherited Mendelian disorder. It is characterised by a short trunk compared to arm span, multiple epiphyseal dysplasia, multiple fractures, hepatosplenomegaly and renal ...
Sudagani, Jaidev
core   +3 more sources

Arrhythmias in type 2 diabetes mellitus

open access: yesIndian Journal of Endocrinology and Metabolism, 2017
Chronic hyperglycaemia of Type 2 diabetes mellitus causes long term damage to heart resulting in coronary artery disease (CAD), myocardial infarction (MI), congestive heart failure (CHF), and sudden death from arrhythmias.
Gaurav Agarwal, Satish Kumar Singh
doaj   +1 more source

Identification of Micronuclei in the Lymphocytes of the Type 2 Diabetes Mellitus According to the Period of Diagnosis as a Biomarker

open access: yesPolytechnic Journal, 2023
Micronuclei in lymphocytes can indicate DNA damage or chromosomal instability. This study aimed to compare the Micronuclei to the different period diagnoses of type 2 diabetes mellitus. Four groups were created out of 140 people: type 2 diabetes mellitus
Harem Othman Smail
doaj   +1 more source

Bromocriptine in type 2 diabetes mellitus

open access: yesIndian Journal of Endocrinology and Metabolism, 2011
Bromocriptine mesylate quick-release was approved by the Food and Drug Administration (FDA) in May 2009, for the treatment of type 2 diabetes. Bromocriptine is thought to act on the circadian neuronal activities in the hypothalamus, to reset an ...
C Shivaprasad, Sanjay Kalra
doaj   +1 more source

Home - About - Disclaimer - Privacy